Jean-Marc A. Nabholtz: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Ocular toxicity and cancer chemotherapy: A review

Taher Al-Tweigeri, Jean-Marc Nabholtz, John Robert Mackey

Journal:

Year:

1996

Language:

english

File:

PDF, 1.50 MB

english, 1996

2

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma : Results of two randomized trials designed for combined analysis

Jacques Bonneterre, Aman Buzdar, Jean-Marc A. Nabholtz, John F. R. Robertson, Bert Thürlimann, Mikael von Euler, Tarek Sahmoud, Alan Webster, Mark Steinberg, Arimidex Writing Committee on behalf of th

Journal:

Year:

2001

Language:

english

File:

PDF, 155 KB

english, 2001

3

An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane

Aman U. Buzdar, John F. R. Robertson, Wolfgang Eiermann, Jean-Marc Nabholtz

Journal:

Year:

2002

Language:

english

File:

PDF, 123 KB

english, 2002

4

Author reply

Jacques Bonneterre, Aman Buzdar, Jean-Marc Nabholtz, John Robertson, Beat Thürlimann, Mikael von Euler, Tarek Sahmoud, Mark Steinberg, Alan Webster

Journal:

Year:

2002

Language:

english

File:

PDF, 45 KB

english, 2002

5

Impact of chemotherapy regimens prior to endocrine therapy : Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial

Aman U. Buzdar, Jean-Paul Guastalla, Jean-Marc Nabholtz, Jack Cuzick, on behalf of the ATAC Trialists' Group

Journal:

Year:

2006

Language:

english

File:

PDF, 228 KB

english, 2006

6

2012 Reverse-transcriptase polymerase chain reaction (RT-PCR) detection of cytokeratin 19 in peripheral blood from healthy volunteers

Diane Severin, Murray Fraser, T. Al-Tweigeri, Jean-Marc Nabholtz, Malcolm C. Paterson

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

1996

Language:

english

File:

PDF, 92 KB

english, 1996

7

Third-generation aromatase inhibitors in the treatment of advanced breast cancer

Jean-Marc A. Nabholtz, David M. Reese

Journal:

Year:

2001

Language:

english

File:

PDF, 517 KB

english, 2001

8

Role of aromatase inhibitors in the upfront adjuvant hormonal therapy of postmenopausal patients with breast cancer

Jean-Marc Nabholtz, Marie-Ange Mouret-Reynier, Xavier Durando, Isabelle Van Praag, Béatrice Nayl, Jean-Pierre Ferriere, Philippe Chollet

Journal:

Indian Journal of Surgical Oncology

Year:

2010

Language:

english

File:

PDF, 152 KB

english, 2010

9

Liarozole fumarate (R85246): a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancer

Paul E. Goss, Amit Oza, Rakesh Goel, Jean-Marc Nabholtz, Roland De Coster, Jan Bruynseels, Caroline Reid, Nancy Wadden, Michael Crump, Lesley M. Tye

Journal:

Breast Cancer Research and Treatment

Year:

2000

Language:

english

File:

PDF, 119 KB

english, 2000

10

Liarozole Fumarate (R85246): In the Treatment of ER Negative, Tamoxifen Refractory or Chemotherapy Resistant Postmenopausal Metastatic Breast Cancer

Paul E. Goss, Kathrin Strasser, Ricardo Marques, Mark Clemons, Amit Oza, Rakesh Goel, Martin Blackstein, Leonard Kaizer, Ernest E. Sterns, Jean-Marc Nabholtz, Roland De Coster, Michael Crump, Mohamed

Journal:

Breast Cancer Research and Treatment

Year:

2000

Language:

english

File:

PDF, 102 KB

english, 2000

11

Responsiveness of the EuroQol in breast cancer patients undergoing high dose chemotherapy

Barbara Conner-Spady, Ceinwen Cumming, Jean-Marc Nabholtz, Philip Jacobs, Douglas Stewart

Journal:

Quality of Life Research

Year:

2001

Language:

english

File:

PDF, 100 KB

english, 2001

12

New adjuvant strategies for breast cancer: Meeting the challenge of integrating chemotherapy and trastuzumab (Herceptin)

Jean-Marc Nabholtz, Dennis Slamon

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 1.28 MB

english, 2001

13

Docetaxel in the treatment of breast cancer: An update on recent studies

Jean-Marc A. Nabholtz, David M. Reese, Mary-Ann Lindsay, Alessandro Riva

Journal:

Seminars in Oncology

Year:

2002

Language:

english

File:

PDF, 85 KB

english, 2002

14

A Phase II Trial of Triamcinolone Hexacetanide for Symptomatic Recurrent Malignant Ascites

John R Mackey, Lori Wood, Jean-Marc Nabholtz, John Jensen, Peter Venner

Journal:

Journal of Pain and Symptom Management

Year:

2000

Language:

english

File:

PDF, 138 KB

english, 2000

15

Advances in the Use of Taxanes in the Adjuvant Therapy of Breast Cancer

Jean-Marc Nabholtz, Jean-Michel Vannetzel, Jean-Francois Llory, Patrick Bouffette

Journal:

Clinical Breast Cancer

Year:

2003

Language:

english

File:

PDF, 124 KB

english, 2003

16

Concurrent weekly carboplatin and radiotherapy for nasopharyngeal carcinoma: report of a joint phase II study

Matthew Parliament, Naresh Jha, Edna Rapp, Colum Smith, Jack MacKinnon, Jean-Marc Nabholtz, John Hanson, Tony Reiman, John Mackey

Journal:

Radiotherapy and Oncology

Year:

2001

Language:

english

File:

PDF, 97 KB

english, 2001

17

Cardiovascular Safety Profiles of Aromatase Inhibitors

Dr Jean-Marc Nabholtz, Joseph Gligorov

Journal:

Year:

2006

Language:

english

File:

PDF, 159 KB

english, 2006

18

The Choice of Adjuvant Combination Therapies with Taxanes: Rationale and Issues Addressed in Ongoing Studies

Jean-Marc A. Nabholtz, Alessandro Riva

Journal:

Clinical Breast Cancer

Year:

2001

Language:

english

File:

PDF, 128 KB

english, 2001

19

Phase III Trial Comparing Granulocyte Colony-Stimulating Factor to Leridistim in the Prevention of Neutropenic Complications in Breast Cancer Patients Treated with Docetaxel/Doxorubicin/Cyclophosphamide: Results of the BCIRG 004 Trial

Jean-Marc Nabholtz, Jacques Cantin, Jose Chang, Raymond Guevin, Ravi Patel, Katherine Tkaczuk, Pavel Vodvarka, Mary-Ann Lindsay, David Reese, Alessandro Riva, John Mackey

Journal:

Clinical Breast Cancer

Year:

2002

Language:

english

File:

PDF, 161 KB

english, 2002

20

HER2-Positive Breast Cancer: Update on Breast Cancer International Research Group Trials

Jean-Marc Nabholtz, David M. Reese, Mary-Ann Lindsay, Alessandro Riva

Journal:

Clinical Breast Cancer

Year:

2002

Language:

english

File:

PDF, 109 KB

english, 2002

21

Docetaxel in the treatment of breast cancer: current experience and future prospects

Nabholtz, Jean-Marc, Gligorov, Joseph

Journal:

Expert Review of Anticancer Therapy

Year:

2005

Language:

english

File:

PDF, 228 KB

english, 2005

22

Anastrozole in the management of breast cancer

Reese, David, Nabholtz, Jean-Marc

Journal:

Expert Opinion on Pharmacotherapy

Year:

2002

Language:

english

File:

PDF, 187 KB

english, 2002

23

Docetaxel/trastuzumab combination therapy for the treatment of breast cancer

Nabholtz, Jean-marc, Gligorov, Joseph

Journal:

Expert Opinion on Pharmacotherapy

Year:

2005

Language:

english

File:

PDF, 191 KB

english, 2005

24

Comparative review of anastrozole, letrozole and exemestane in the management of early breast cancer

Nabholtz, Jean-Marc, Mouret-Reynier, Marie-Ange, Durando, Xavier, Van Praagh, Isabelle, Al-Sukhun, Sana, Ferriere, Jean-Pierre, Chollet, Philippe

Journal:

Expert Opinion on Pharmacotherapy

Year:

2009

Language:

english

File:

PDF, 516 KB

english, 2009

25

The role of taxanes in the treatment of breast cancer

Nabholtz, Jean-Marc, Gligorov, Joseph

Journal:

Expert Opinion on Pharmacotherapy

Year:

2005

Language:

english

File:

PDF, 352 KB

english, 2005

26

Combination chemotherapy for metastatic breast cancer

Nabholtz, Jean-Marc A, Reese, David M, Lindsay, Mary-Ann, Riva, Alessandro

Journal:

Expert Review of Anticancer Therapy

Year:

2002

Language:

english

File:

PDF, 213 KB

english, 2002

27

Chemotherapy of breast cancer: are the taxanes going to change the natural history of breast cancer?

Nabholtz, Jean-Marc, Tonkin, Katia, Smylie, Mike, Au, Heather-Jane, Lindsay, Mary-Ann, Mackey, John

Journal:

Expert Opinion on Pharmacotherapy

Year:

2000

Language:

english

File:

PDF, 120 KB

english, 2000

28

Role of Anastrozole across the Breast Cancer Continuum: From Advanced to Early Disease and Prevention

Nabholtz, Jean-Marc

Journal:

Year:

2006

Language:

english

File:

PDF, 147 KB

english, 2006

29

Taxane therapy for early stage breast cancer

Nabholtz, Jean-Marc, Gligorov, Joseph

Journal:

Year:

2006

Language:

english

File:

PDF, 149 KB

english, 2006

30

Anastrozole therapy for postmenopausal women with early breast cancer

Nabholtz, Jean-Marc

Journal:

Expert Review of Obstetrics & Gynecology

Year:

2007

Language:

english

File:

PDF, 356 KB

english, 2007

31

Responsiveness of the EuroQol in Breast Cancer Patients Undergoing High Dose Chemotherapy

Barbara Conner-Spady, Ceinwen Cumming, Jean-Marc Nabholtz, Philip Jacobs and Douglas Stewart

Journal:

Quality of Life Research

Year:

2001

Language:

english

File:

PDF, 846 KB

english, 2001

32

Endogenous Erythropoietin, Tumor Necrosis Factor-α and Interleukin-6 Levels after Peripheral Blood Stem Cell Transplantation

Matsuzaki, Akinobu, Nabholtz, Jean-Marc, Nahirniak, Susan, Janowska-Wieczorek, Anna

Journal:

Hematology (Maney Publishing)

Year:

1997

Language:

english

File:

PDF, 755 KB

english, 1997

33

Growth Factors and Cytokines Upregulate Gelatinase Expression in Bone Marrow CD34+ Cells and Their Transmigration Through Reconstituted Basement Membrane

Janowska-Wieczorek, Anna, Marquez, Leah A., Nabholtz, Jean-Marc, Cabuhat, Maria L., MontanÌo, Jencet, Chang, Hung, Rozmus, Jacob, Russell, James A., Edwards, Dylan R., Turner, A. Robert

Journal:

Year:

1999

File:

PDF, 261 KB

1999